• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view.

作者信息

Khalil Shadi, de Riese Werner

机构信息

Texas Tech University Health Sciences Center, Dept. of Urology, 3601 4th Street, Suite 3B 100, Lubbock, TX, 79430, USA.

出版信息

World J Urol. 2017 Oct;35(10):1633-1634. doi: 10.1007/s00345-017-2031-7. Epub 2017 Mar 17.

DOI:10.1007/s00345-017-2031-7
PMID:28314906
Abstract
摘要

相似文献

1
Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view.良性前列腺增生（BPH）体积与前列腺癌的关联：来自一所学术机构的连续数据，基于当前科学观点。
World J Urol. 2017 Oct;35(10):1633-1634. doi: 10.1007/s00345-017-2031-7. Epub 2017 Mar 17.
2
Is there a relationship between benign prostatic hyperplasia and prostatic cancer?良性前列腺增生与前列腺癌之间有关系吗？
Eur Urol. 1991;20 Suppl 1:31-5. doi: 10.1159/000471743.
3
Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.度他雄胺可降低前列腺癌风险，从而改善良性前列腺增生的预后：度他雄胺减少前列腺癌事件（REDUCE）试验的二次分析。
Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20.
4
Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.白细胞介素-17和血管生成素-2升高与良性前列腺增生中前列腺大小的关联。
Aging Male. 2017 Jun;20(2):115-118. doi: 10.1080/13685538.2017.1284778. Epub 2017 Feb 21.
5
Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.良性前列腺增生和前列腺癌中植物雌激素的组织水平及其与前列腺疾病的关联。
Urology. 2004 Oct;64(4):707-11. doi: 10.1016/j.urology.2004.04.046.
6
The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.经尿道前列腺切除术后良性前列腺增生男性中前列腺干细胞抗原（PSCA）mRNA表达与后续前列腺癌风险的关联。
Prostate. 2008 Feb 1;68(2):190-9. doi: 10.1002/pros.20701.
7
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.在患有尿潴留和前列腺良性增生或前列腺腺癌的患者中，组织学前列腺炎的意义。
BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.
8
Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.无尿潴留表现的良性前列腺增生或前列腺腺癌男性患者中组织学前列腺炎的患病率
S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095.
9
Serum concentrations of folate vitamers in patients with a newly diagnosed prostate cancer or hyperplasia.新诊断的前列腺癌或前列腺增生患者血清中叶酸维生素的浓度。
Clin Biochem. 2018 Jun;56:41-46. doi: 10.1016/j.clinbiochem.2018.04.011. Epub 2018 Apr 16.
10
[The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].[前列腺特异性抗原与前列腺体积的比值。改善良性前列腺增生与局限性前列腺癌之间的鉴别诊断]
Urologe A. 1993 May;32(3):250-3.

引用本文的文献

1
ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.ESTAT3 抑制剂 AG-490 通过 miR-503-5p 体内和体外抑制前列腺癌的生长。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948062. doi: 10.1177/1533033820948062.

本文引用的文献

1
Association of prostate volume with incidence and aggressiveness of prostate cancer.前列腺体积与前列腺癌发病率及侵袭性的关联
Res Rep Urol. 2016 Oct 26;8:201-205. doi: 10.2147/RRU.S117963. eCollection 2016.
2
Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.大前列腺中良性前列腺增生（BPH）与前列腺癌之间的相互作用：一项回顾性数据综述。
Int Urol Nephrol. 2016 Jan;48(1):91-7. doi: 10.1007/s11255-015-1146-2. Epub 2015 Nov 21.
3
BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
良性前列腺增生：前列腺癌的一个迹象？前列腺癌与环境研究（PROtEuS）的结果
World J Urol. 2015 Dec;33(12):2063-9. doi: 10.1007/s00345-015-1546-z. Epub 2015 Apr 1.
4
Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates.磁共振成像/超声融合靶向活检诊断大体积前列腺与小体积前列腺临床显著前列腺癌的准确性。
J Urol. 2015 Sep;194(3):669-73. doi: 10.1016/j.juro.2015.03.025. Epub 2015 Mar 14.
5
Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume.基于腺体体积增加穿刺活检针数优化前列腺癌诊断
Int J Clin Exp Pathol. 2012;5(9):892-9. Epub 2012 Oct 20.
6
The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.度他雄胺对前列腺外周带和移行带的影响以及移行带指数在预测治疗反应中的价值。
J Urol. 2007 Apr;177(4):1408-13. doi: 10.1016/j.juro.2006.11.095.
7
The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.前列腺体积与前列腺癌检测中延长穿刺活检的关系。
J Urol. 2003 Jan;169(1):130-5. doi: 10.1016/S0022-5347(05)64052-9.